• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜组织衍生生物墨水对3D细胞打印技术的成熟及保护作用

Maturation and Protection Effect of Retinal Tissue-Derived Bioink for 3D Cell Printing Technology.

作者信息

Kim Jongmin, Kong Jeong Sik, Kim Hyeonji, Han Wonil, Won Jae Yon, Cho Dong-Woo

机构信息

Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea.

School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea.

出版信息

Pharmaceutics. 2021 Jun 23;13(7):934. doi: 10.3390/pharmaceutics13070934.

DOI:10.3390/pharmaceutics13070934
PMID:34201702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8309106/
Abstract

Retinal degeneration is a leading cause of incurable vision loss and blindness. The increasing incidence of retinal degeneration has triggered research into the development of in vitro retinal models for drug development and retinal alternatives for transplantation. However, the complex retinal structure and the retinal microenvironment pose serious challenges. Although 3D cell printing technology has been widely used in tissue engineering, including in vitro model development and regeneration medicine, currently available bioinks are insufficient to recapitulate the complex extracellular matrix environment of the retina. Therefore, in this study, we developed a retinal decellularized extracellular matrix (RdECM) from the porcine retina and evaluated its characteristics. The RdECM conserved the ECM components from the native retina without cellular components. Then, we mixed the RdECM with collagen to form a bioink and confirmed its suitability for 3D cell printing. We further studied the effect of the RdECM bioink on the differentiation of Muller cells. The retinal protective effect of the RdECM bioink was confirmed through a retinal degeneration animal model. Thus, we believe that the RdECM bioink is a promising candidate for retinal tissue engineering.

摘要

视网膜变性是导致不可治愈的视力丧失和失明的主要原因。视网膜变性发病率的不断上升引发了对用于药物开发的体外视网膜模型以及用于移植的视网膜替代物的研究。然而,复杂的视网膜结构和视网膜微环境带来了严峻挑战。尽管3D细胞打印技术已广泛应用于组织工程,包括体外模型开发和再生医学,但目前可用的生物墨水不足以重现视网膜复杂的细胞外基质环境。因此,在本研究中,我们从猪视网膜中开发了一种视网膜脱细胞细胞外基质(RdECM)并评估了其特性。RdECM保留了来自天然视网膜的细胞外基质成分,而没有细胞成分。然后,我们将RdECM与胶原蛋白混合形成生物墨水,并确认了其适用于3D细胞打印。我们进一步研究了RdECM生物墨水对穆勒细胞分化的影响。通过视网膜变性动物模型证实了RdECM生物墨水的视网膜保护作用。因此,我们认为RdECM生物墨水是视网膜组织工程的一个有前途的候选材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/56f6e6d9047c/pharmaceutics-13-00934-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/df2d2f934241/pharmaceutics-13-00934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/218472bb56ea/pharmaceutics-13-00934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/75b938742a02/pharmaceutics-13-00934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/56deafd828e5/pharmaceutics-13-00934-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/4e9e8a0bcc08/pharmaceutics-13-00934-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/56f6e6d9047c/pharmaceutics-13-00934-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/df2d2f934241/pharmaceutics-13-00934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/218472bb56ea/pharmaceutics-13-00934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/75b938742a02/pharmaceutics-13-00934-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/56deafd828e5/pharmaceutics-13-00934-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/4e9e8a0bcc08/pharmaceutics-13-00934-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/8309106/56f6e6d9047c/pharmaceutics-13-00934-g006.jpg

相似文献

1
Maturation and Protection Effect of Retinal Tissue-Derived Bioink for 3D Cell Printing Technology.视网膜组织衍生生物墨水对3D细胞打印技术的成熟及保护作用
Pharmaceutics. 2021 Jun 23;13(7):934. doi: 10.3390/pharmaceutics13070934.
2
Development of Liver Decellularized Extracellular Matrix Bioink for Three-Dimensional Cell Printing-Based Liver Tissue Engineering.用于基于三维细胞打印的肝脏组织工程的去细胞化肝脏细胞外基质生物墨水的开发。
Biomacromolecules. 2017 Apr 10;18(4):1229-1237. doi: 10.1021/acs.biomac.6b01908. Epub 2017 Mar 21.
3
ECM Based Bioink for Tissue Mimetic 3D Bioprinting.基于细胞外基质的生物墨水用于组织模拟的 3D 生物打印。
Adv Exp Med Biol. 2018;1064:335-353. doi: 10.1007/978-981-13-0445-3_20.
4
3D cell printing of in vitro stabilized skin model and in vivo pre-vascularized skin patch using tissue-specific extracellular matrix bioink: A step towards advanced skin tissue engineering.使用组织特异性细胞外基质生物墨水的体外稳定皮肤模型和体内预血管化皮肤贴片的 3D 细胞打印:迈向先进的皮肤组织工程的一步。
Biomaterials. 2018 Jun;168:38-53. doi: 10.1016/j.biomaterials.2018.03.040. Epub 2018 Mar 23.
5
Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing.脱细胞细胞外基质:迈向生物墨水制造下一代来源的一步。
Biofabrication. 2017 Aug 4;9(3):034104. doi: 10.1088/1758-5090/aa7e98.
6
Development of Printable Natural Cartilage Matrix Bioink for 3D Printing of Irregular Tissue Shape.用于不规则组织形状3D打印的可打印天然软骨基质生物墨水的研发。
Tissue Eng Regen Med. 2017 Dec 28;15(2):155-162. doi: 10.1007/s13770-017-0104-8. eCollection 2018 Apr.
7
3D bioprinting of mechanically tuned bioinks derived from cardiac decellularized extracellular matrix.源自心脏脱细胞细胞外基质的机械调谐生物墨水的3D生物打印
Acta Biomater. 2021 Jan 1;119:75-88. doi: 10.1016/j.actbio.2020.11.006. Epub 2020 Nov 7.
8
Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro.脱细胞细胞外基质生物墨水及体外增强心脏组织发育的外部刺激。
Acta Biomater. 2019 Sep 1;95:188-200. doi: 10.1016/j.actbio.2019.04.026. Epub 2019 Apr 12.
9
A Photo-Crosslinkable Kidney ECM-Derived Bioink Accelerates Renal Tissue Formation.一种光交联性肾脏细胞外基质衍生生物墨水加速肾脏组织形成。
Adv Healthc Mater. 2019 Apr;8(7):e1800992. doi: 10.1002/adhm.201800992. Epub 2019 Feb 6.
10
Bioprinting of 3D Tissue Models Using Decellularized Extracellular Matrix Bioink.使用脱细胞细胞外基质生物墨水进行3D组织模型的生物打印。
Methods Mol Biol. 2017;1612:381-390. doi: 10.1007/978-1-4939-7021-6_27.

引用本文的文献

1
Three-Dimensional Bioprinting for Retinal Tissue Engineering.用于视网膜组织工程的三维生物打印
Biomimetics (Basel). 2024 Dec 1;9(12):733. doi: 10.3390/biomimetics9120733.
2
Three-Dimensional Bioprinting: A Comprehensive Review for Applications in Tissue Engineering and Regenerative Medicine.三维生物打印:组织工程与再生医学应用综述
Bioengineering (Basel). 2024 Jul 31;11(8):777. doi: 10.3390/bioengineering11080777.
3
Recent Advances in the Application of 3D-Printing Bioinks Based on Decellularized Extracellular Matrix in Tissue Engineering.

本文引用的文献

1
Development of 3D Printed Bruch's Membrane-Mimetic Substance for the Maturation of Retinal Pigment Epithelial Cells.3D 打印仿生脉络膜基质用于视网膜色素上皮细胞成熟。
Int J Mol Sci. 2021 Jan 22;22(3):1095. doi: 10.3390/ijms22031095.
2
Recent Strategies in Extrusion-Based Three-Dimensional Cell Printing toward Organ Biofabrication.基于挤压的三维细胞打印用于器官生物制造的最新策略
ACS Biomater Sci Eng. 2019 Mar 11;5(3):1150-1169. doi: 10.1021/acsbiomaterials.8b00691. Epub 2019 Feb 4.
3
3D Cell Printing of Tissue/Organ-Mimicking Constructs for Therapeutic and Drug Testing Applications.
基于脱细胞细胞外基质的3D打印生物墨水在组织工程中的应用研究进展
ACS Omega. 2024 May 29;9(23):24219-24235. doi: 10.1021/acsomega.4c02847. eCollection 2024 Jun 11.
4
Advances in the engineering of the outer blood-retina barrier: From in-vitro modelling to cellular therapy.血视网膜外屏障工程学进展:从体外建模到细胞治疗
Bioact Mater. 2023 Aug 12;31:151-177. doi: 10.1016/j.bioactmat.2023.08.003. eCollection 2024 Jan.
5
Extracellular matrix-derived scaffolds in constructing artificial ovaries for ovarian failure: a systematic methodological review.用于卵巢功能衰竭的人工卵巢构建中细胞外基质衍生支架:系统方法学综述
Hum Reprod Open. 2023 Apr 20;2023(2):hoad014. doi: 10.1093/hropen/hoad014. eCollection 2023.
三维细胞打印构建组织/器官仿生结构用于治疗和药物测试应用。
Int J Mol Sci. 2020 Oct 20;21(20):7757. doi: 10.3390/ijms21207757.
4
Decellularized Extracellular Matrix-based Bioinks for Engineering Tissue- and Organ-specific Microenvironments.基于去细胞细胞外基质的生物墨水用于构建组织和器官特异性微环境。
Chem Rev. 2020 Oct 14;120(19):10608-10661. doi: 10.1021/acs.chemrev.9b00808. Epub 2020 Jul 31.
5
Experimental Models in Neovascular Age Related Macular Degeneration.新生血管性年龄相关性黄斑变性的实验模型。
Int J Mol Sci. 2020 Jun 29;21(13):4627. doi: 10.3390/ijms21134627.
6
Dynamic Bioinks to Advance Bioprinting.推动生物打印的动态生物墨水
Adv Healthc Mater. 2020 Aug;9(15):e1901798. doi: 10.1002/adhm.201901798. Epub 2020 Feb 26.
7
Protection of retinal function and morphology in MNU-induced retinitis pigmentosa rats by ALDH2: an in-vivo study.ALDH2 对 MNU 诱导的视网膜色素变性大鼠视网膜功能和形态的保护作用:一项体内研究。
BMC Ophthalmol. 2020 Feb 18;20(1):55. doi: 10.1186/s12886-020-1330-8.
8
Directed differential behaviors of multipotent adult stem cells from decellularized tissue/organ extracellular matrix bioinks.去细胞化组织/器官细胞外基质生物墨水定向诱导多能成体干细胞的差异化行为。
Biomaterials. 2019 Dec;224:119496. doi: 10.1016/j.biomaterials.2019.119496. Epub 2019 Sep 12.
9
Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.将类器官和器官芯片技术融合,在人眼芯片平台上生成复杂的多层组织模型。
Elife. 2019 Aug 27;8:e46188. doi: 10.7554/eLife.46188.
10
Complement system and age-related macular degeneration: drugs and challenges.补体系统与年龄相关性黄斑变性:药物与挑战
Drug Des Devel Ther. 2019 Jul 19;13:2413-2425. doi: 10.2147/DDDT.S206355. eCollection 2019.